Stem Cell Therapy and Models for Autism Spectrum Disorder: Insights and Research.

This review looks at using stem cells to help children with autism. Researchers are studying whether stem cell treatments might improve autism symptoms and are also using stem cells to better understand how autism develops. The review covers both animal studies and some human trials in children and teenagers. While this is still experimental research, scientists are exploring stem cells as a potential new treatment approach since there are currently no medications specifically approved for autism's main symptoms.

This review examines stem cell therapy approaches for autism spectrum disorder (ASD), covering both treatment applications and research models. The authors discuss stem cell-based transplantation studies in animal models of ASD, exploring potential improvements in symptoms and underlying mechanisms. They also review clinical applications in pediatric and adolescent populations to assess treatment efficacy. Additionally, the review addresses recent developments in stem cell-based disease models, including cerebral organoids for both syndromic and non-syndromic ASD forms.

The review highlights the potential of stem cells as both therapeutic interventions and research tools for understanding ASD pathogenesis in tissue-like environments.

Stem cell therapy represents a novel experimental approach for ASD treatment, particularly relevant given the absence of FDA-approved medications for core symptoms. However, this remains early-stage research requiring further clinical trials to establish safety and efficacy before clinical implementation.

As a review paper, findings depend on quality of cited studies. The abstract does not specify the number of studies reviewed, methodology for study selection, or detailed outcomes. Sample sizes and study quality of reviewed research are not reported, limiting assessment of evidence strength.

Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by impaired social communication, repetitive behavior patterns, and atypical sensory perception. The Autism and Developmental Disabilities Monitoring Network reports that approximately 1 in 36 children are diagnosed with ASD, highlighting the increasing prevalence and the pressing need for innovative treatment approaches. Medications commonly used in ASD primarily aim to manage associated symptoms, as there are currently no FDA-approved medications specifically for treating ASD core symptoms. Stem cells have demonstrated significant potential in cell-based therapies for ASD and have been utilizedmodels to investigate the pathogenesis of the condition.

This review focuses on the recent advancements in stem cell-based transplantation in animal models of ASD, aiming to explore the improvement of ASD symptoms and the underlying mechanisms involved. It also discussed the application of stem cell-based transplantation in pediatric and adolescent populations with ASD to evaluate treatment efficacy and potential preventive strategies. Furthermore, recent efforts are addressed in developing stem cell-based models for both syndromic and non-syndromic forms of ASD, emphasizing studies that utilize cerebral organoids for modeling ASD, which facilitate the exploration of disease mechanisms within a tissue-like environment.